Evaluation of the hemostatic effect of 25% red mangrove gel in acute hemorrhage
Keywords:
animals, hemorrhage, hemostasis, hemostatics, rats, Rhizophoraceae.Abstract
Introduction: In traditional medicine, hemostatic effects are attributed to parts of the red mangrove plant (Rhizophora mangle).
Objective: To evaluate the hemostatic effect of 25% red mangrove gel on acute hemorrhage.
Methods: A study was carried out in an animal model with 5 groups of albino rats; group I (warfarin), II (phytomenadione), III (0.9% sodium chloride), IV (untreated control) and V (25% red mangrove gel). One limb amputation was produced and the bleeding time (in min) and the amount of bleeding (in g) were measured. A mean comparison analysis was performed with the results of the measurements.
Results: For bleeding time, the means and standard deviations were as follows: Group I (3.12 ± 0.35), group II (1.25 ± 0.30), group III (2.94 ± 0.42); group IV (2.10 ± 0.36) and group V (0.71 ± 0.10). For the amount of bleeding, the means and standard deviations were: Group I (2.97 ± 0.20), group II (1.15 ± 0.38), group III (2.36 ± 0.30), group IV (2.90 ± 0.92) and group V (1.16 ± 0.36). For both variables there were statistically significant differences of groups II and V (p< 0.05) with the other groups and none between group II and IV.
Conclusions: The 25% red mangrove gel presents hemostatic effect similar to phytomenadione, according to the duration and amount of bleeding.
Downloads
References
2. Suman DO. El ecosistema de manglar en América Latina y la cuenca del Caribe: su manejo y conservación. Florida, Miami: Rosenstiel School of Marine and Atmospheric Science, Universidad de Miami & New Yor, The Tinker Foundation; 1994. [acceso: 14/06/2022]. Disponible en: http://www.invemar.org.co/redcostera1/invemar/docs/RinconLiterario/2012/octubre/B-6.pdf
3. Regalado AI, Sánchez LM, Mancebo B. Rhizophora mangle L. (mangle rojo): Una especie con potencialidades de uso terapéutico. Journal of Pharmacy & Pharmacognosy Research. 2016 [acceso: 14/06/2022]; 4(1):1-17. Disponible en: https://www.redalyc.org/pdf/4960/496053933001.pdf
4. Bruneton J. Farmacognosia. Fitoquímica. Plantas medicinales. Madrid: Editorial Acribia; 2001.
5. Ferreira F, Santos S, Barros T, Rossi Alva J, Fernández L. Atividade antibacteriana in vitro de extratos de Rhizophora mangle L. Rev Bras Pl. Med. 2011; 13(3):305-10. DOI: 10.1590/S1516-05722011000300009
6. Marroquín Tintí MN. Evaluación de la actividad cicatrizante de extractos etanólicos de hoja y corteza de mangle rojo (Rhizophora mangle L) mediante técnicas in vitro, para su aprovechamiento en la industria fitofarmacéutica [Tesis de maestría en ciencias]. Guatemala: Universidad de San Carlos de Guatemala, Facultad De Ciencias Químicas y Farmacia; 2016. [acceso: 14/06/2022]. Disponible en: https://docs.bvsalud.org/biblioref/2018/08/911593/evaluacion-de-la-actividad-cicatrizante-de-extractos-etanolicos_hjDkizu.pdf
7. Bulnes C, Fernandez O, Navarro D, Marrero E, Rueda D, Figueroa O. Healing effect of a red mangrove extract on open aseptic wounds in rats. Rev Salud Anim. 2001 [acceso: 14/06/2022]; 23(2):102-8. Disponible en: https://go.gale.com/ps/i.do?id=GALE%7CA146893268&sid=googleScholar&v=2.1&it=-r&linkaccess=abs&issn=0253570X&p=IFME&sw=w&userGroupName=anon%7E134681a0
8. Meira de-Faria F, Alves Almeida AC, Luiz-Ferreira A, Takayama C, Dunder RJ, Aparecido da Silva A, et al. Antioxidant Action of Mangrove Polyphenols against Gastric Damage Induced by Absolute Ethanol and Ischemia-Reperfusion in the Rat. The Scientific World Journal. 2012: 327071. DOI: 10.1100/2012/327071
9. Marrero E, Sanchez J, de Armas E, Escobar A, Melchor G, Abad MJ, et al. COX-2 and sPLA2 inhibitory activity of aqueous extract and polyphenols of Rhizophora mangle (red mangrove). FITOTERAPIA. 2006; 77: 313-15. DOI: I0.10 16/j.fitote.2006.03.009
10. Marroquín Tintí MN. Actividad biológica y caracterización química de los extractos de las hojas de Rhizophora mangle L., como una alternativa fitofarmacéutica en la cicatrización. Ciencia, tecnología y salud. 2016; 3(1):73-82. DOI: 10.36829/63CTS.v3i1.155
11. Grimaldo-Gómez FA. Fisiología de la hemostasia. Revista Mexicana de Anestesiología. 2017 [acceso: 27/07/2022]; 40(Supl 2):398-400. Disponible en: https://www.medigraphic.com/pdfs/rma/cma-2017/cmas172b.pdf
12. UpToDate. Topical hemostatic agents for managing bleeding. Wolters Kluwer, UpToDate; 2022 [acceso: 14/06/2022]. Disponible en: https://www.uptodate.com/contents/image?imageKey=SURG%2F71852
13. Vandamme TF. Use of rodents as models of human diseases. J Pharm Bioallied Sci. 2014; 6(1):2-9. DOI: 10.4103/0975-7406.124301
14. Hickman DL, Johnson J, Vemulapalli TH, Crisler JR, Shepherd R. Commonly Used Animal Models. Principles of Animal Research for Graduate and Undergraduate Students. 2017: 117-75. DOI: 10.1016/B978-0-12-802151-4.00007-4
15. Meneau Hernández RI. Métodos Alternativos en Toxicología. Revista CENIC Ciencias Biológicas. 2014 [acceso: 14/06/2022]; 45(1):11-21. Disponible en: https://www.redalyc.org/pdf/1812/181230079003.pdf
16. Kirkpatrick LA, Feeney BC. Excerpt from: A Simple Guide to SPSS for Windows. Canada: Western University; 2004. [acceso: 14/06/2022]. Disponible: https://instruct.uwo.ca/biology/345a/Stats.pdf
17. Consejo de Estado República de Cuba. Decreto-Ley 31/2021 De Bienestar Animal. La Habana: Gaceta Oficial de la República de Cuba No. 25 Extraordinaria de 10 de abril de 2021. [acceso: 27/07/2022]. Disponible en: https://www.gacetaoficial.gob.cu/sites/default/files/goc-2021-ex25-.pdf
18. Consejo de Estado República de Cuba. Decreto 38/2021 Reglamento del Decreto-Ley 31 de Bienestar Animal. La Habana: Gaceta Oficial de la República de Cuba No. 25 Extraordinaria de 10 de abril de 2021. [acceso: 27/07/2022]. Disponible en: https://www.gacetaoficial.gob.cu/sites/default/files/goc-2021-ex25-.pdf
19. CECMED. Regulación no. 64/13. Lineamientos para la constitución y funcionamiento de los comités institucionales para el cuidado y uso de los animales de laboratorio (CICUAL). La Habana: Centro para el Control Estatal de Medicamentos y Equipos Médicos; 2013. [acceso: 27/07/2022]. Disponible en: https://www.cecmed.cu/sites/default/files/adjuntos/Reglamentacion/reg_no_64_2013-_lineamientos_cicual-1.pdf
20. da Silva LA, Lira EC, Bastos Leal L, de Santana ES, de Franca Barbosa IC, de Albuquerque Silva YJ, et al. Prevention of necrosis in ischemic skin flaps using hydrogel of Rhizophora mangle. Injury. 2022; 53(7):2462-69. DOI: 10.1016/j.injury.2022.03.034
21. Vademecum. Warfarina. Madrid: Vidal Vademecum Spain; 2021 [acceso: 27/07/2022]. Disponible en: https://www.vademecum.es/principios-activos-warfarina-b01aa03
22. CECMED. Resumen de las características del producto: Cloruro de sodio 0,9 %. La Habana: Centro para Control Estatal de Medicamentos y Equipos Médicos; 2017. [acceso: 14/06/2022]. Disponible en: https://www.cecmed.cu/file/5731/download?token=Ej_3QGsT
23. CECMED. Resumen de las características del producto: Fitomenadiona. La Habana: Centro para Control Estatal de Medicamentos y Equipos Médicos; 2017. [acceso: 14/06/2022]. Disponible en: https://www.cecmed.cu/file/6443/download?token=xNJ4mwQb
Published
How to Cite
Issue
Section
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.